Donatella Polizzi

900 total citations
17 papers, 774 citations indexed

About

Donatella Polizzi is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Donatella Polizzi has authored 17 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Donatella Polizzi's work include Cancer therapeutics and mechanisms (6 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (5 papers). Donatella Polizzi is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Cancer-related Molecular Pathways (6 papers) and Metal complexes synthesis and properties (5 papers). Donatella Polizzi collaborates with scholars based in Italy and United States. Donatella Polizzi's co-authors include Graziella Pratesi, Franco Zunino, Rosanna Supino, Paola Perego, Gabriella Pezzoni, C. Manzotti, Nicholas P. Farrell, Michelandrea De Cesare, Giuliana Cassinelli and Monica Tortoreto and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Donatella Polizzi

17 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donatella Polizzi Italy 14 465 383 174 67 58 17 774
Claudia Caserini Italy 13 578 1.2× 570 1.5× 179 1.0× 90 1.3× 61 1.1× 15 919
Mitsunori Okabe Japan 9 556 1.2× 409 1.1× 101 0.6× 81 1.2× 53 0.9× 9 958
H.H. Fiebig Germany 16 440 0.9× 387 1.0× 273 1.6× 92 1.4× 96 1.7× 41 883
Klaus Urbahns Germany 15 192 0.4× 283 0.7× 173 1.0× 30 0.4× 53 0.9× 27 683
M C Bibby United Kingdom 18 383 0.8× 609 1.6× 307 1.8× 258 3.9× 62 1.1× 42 1.2k
Cara A. Rabik United States 8 740 1.6× 738 1.9× 291 1.7× 205 3.1× 131 2.3× 14 1.6k
Maria Kartalou United States 9 658 1.4× 1.0k 2.6× 232 1.3× 241 3.6× 67 1.2× 9 1.5k
Andrew McGown United Kingdom 11 228 0.5× 325 0.8× 107 0.6× 111 1.7× 37 0.6× 28 661
G. M. Tozer United Kingdom 11 264 0.6× 647 1.7× 226 1.3× 353 5.3× 91 1.6× 14 1.3k
Bruce E. Tomczuk United States 20 396 0.9× 465 1.2× 416 2.4× 80 1.2× 29 0.5× 37 1.1k

Countries citing papers authored by Donatella Polizzi

Since Specialization
Citations

This map shows the geographic impact of Donatella Polizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donatella Polizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donatella Polizzi more than expected).

Fields of papers citing papers by Donatella Polizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donatella Polizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donatella Polizzi. The network helps show where Donatella Polizzi may publish in the future.

Co-authorship network of co-authors of Donatella Polizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Donatella Polizzi. A scholar is included among the top collaborators of Donatella Polizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donatella Polizzi. Donatella Polizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Perego, Paola, Elisabetta Corna, Michelandrea De Cesare, et al.. (2001). Role of Apoptosis and Apoptosis-Related Genes in Cellular Response and Antitumor Efficacy of Anthracyclines. Current Medicinal Chemistry. 8(1). 31–37. 67 indexed citations
2.
Cassinelli, Giuliana, Rosanna Supino, Paola Perego, et al.. (2001). A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes. International Journal of Cancer. 92(5). 738–747. 55 indexed citations
3.
Moretti, Roberta M., Marina Montagnani Marelli, Marcella Motta, et al.. (2001). Activation of the orphan nuclear receptor ROR? induces growth arrest in androgen-independent DU 145 prostate cancer cells. The Prostate. 46(4). 327–335. 24 indexed citations
4.
Polizzi, Donatella, Michelandrea De Cesare, Franco Zunino, et al.. (2001). Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice. European Journal of Cancer. 37(3). 431–437. 11 indexed citations
5.
Supino, Rosanna, Donatella Polizzi, Graziella Pratesi, et al.. (2001). A Novel 9-Aza-Anthrapyrazole Effective against Human Prostatic Carcinoma Xenografts. Oncology. 61(3). 234–242. 13 indexed citations
6.
Pratesi, Graziella, Donatella Polizzi, Paola Perego, Laura Dal Bo, & Franco Zunino. (2000). Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs. Biochemical Pharmacology. 60(1). 77–82. 22 indexed citations
7.
Cassinelli, Giuliana, Cinzia Lanzi, Romolo A. Gambetta, et al.. (2000). Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin. Biochemical Pharmacology. 59(12). 1539–1547. 48 indexed citations
8.
Manzotti, C., Graziella Pratesi, E. MENTA, et al.. (2000). BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.. PubMed. 6(7). 2626–34. 154 indexed citations
9.
Polizzi, Donatella, Graziella Pratesi, Silvia Monestiroli, et al.. (2000). Oral efficacy and bioavailability of a novel taxane.. PubMed. 6(5). 2070–4. 39 indexed citations
10.
Pratesi, Graziella, Paola Perego, Donatella Polizzi, et al.. (1999). A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts. British Journal of Cancer. 80(12). 1912–1919. 105 indexed citations
11.
Polizzi, Donatella, Graziella Pratesi, Monica Tortoreto, et al.. (1999). A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.. PubMed. 59(5). 1036–40. 49 indexed citations
12.
Zunino, Franco, Giuliana Cassinelli, Donatella Polizzi, & Paola Perego. (1999). Molecular mechanisms of resistance to taxanes and therapeutic implications. Drug Resistance Updates. 2(6). 351–357. 29 indexed citations
13.
Dondi, D., Roberta M. Moretti, Marina Montagnani Marelli, et al.. (1998). Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice. International Journal of Cancer. 76(4). 506–511. 45 indexed citations
14.
Cesare, Michelandrea De, Graziella Pratesi, Alessandro Giusti, Donatella Polizzi, & Franco Zunino. (1998). Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts. British Journal of Cancer. 77(3). 434–439. 27 indexed citations
15.
Pratesi, Graziella, Michelandrea De Cesare, Claudia Caserini, et al.. (1998). Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.. PubMed. 4(11). 2833–9. 30 indexed citations
16.
Arcamone, F, Fabio Animati, Mario Bigioni, et al.. (1997). Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In Vivo. JNCI Journal of the National Cancer Institute. 89(16). 1217–1223. 54 indexed citations
17.
Chiaramonte, Raffaella, et al.. (1997). P1GF-saporin fusion protein: a potential anti-angiogenic agent.. PubMed. 12(8). 649–57. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026